Transpire Bio, a development-stage biopharmaceutical company, opened a new research facility and global headquarters in Weston, FL. In a statement the company said that it is committed to harnessing the power of inhaled drug delivery to improve patient access and to develop innovative treatments where current therapeutic options are lacking.

Transpire Bio selected Broward County for its new facility location because of the rapidly emerging biomedical hub in the region. By creating over 50 new jobs over the next 24 months, Transpire Bio will contribute to Florida’s innovation economy and pharmaceutical manufacturing workforce. The new site is a research and development facility and will include finished product manufacturing for development purposes.

“Transpire Bio is motivated by the opportunity to make a lasting impact on patients’ lives when it comes to inhaled therapies,” said Xian-Ming Zeng, CEO of Transpire Bio. “Our mission is to develop generic and innovative inhalation products to improve patient access to essential medicines and address unmet medical needs.”